Deba Pharma SA
1.2 FTEThe score of Deba Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +17 % Total assets +11 % Headcount (avg FTE) +140 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Deba Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jul 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 27 Jul 2024
- Year ended 31 Dec 2022filed on 19 Jul 2023
- Year ended 31 Dec 2021filed on 18 Jul 2022
Deba Pharma's financial analysis
- Solvency94.4%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Deba Pharma
Deba Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0434.737.865
- VAT number
- BE0434737865
- Peppol
- Registered · 0208:0434737865 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 15 Jul 1988
- Registered office
- 8510 Kortrijk
- Size
- Micro · 1.2 FTE
- Latest accounts
- 2025 · filed on 24 Jul 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Deba Pharma (SA) has been based in Kortrijk since 1988, active in: manufacture of medicaments. For 2025, it reports a net profit of €2.10m and equity of €6.20m; its revenue is not published. With 1.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 94.4%, above the median of its sector (47.2%).
Companies similar to Deba Pharma
Companies in the same business, of comparable size and area, outside its group.
- Revogan Wholesale of other food Ghent · balance sheet €6.86m
- ALL-in-1 Wholesale of pharmaceutical and medical goods Schelle · balance sheet €8.97m
- Surveal Pharma Wholesale of pharmaceutical and medical goods Ixelles · balance sheet €5.47m
- Laboratoires Forte Pharma Benelux Wholesale of other food Brussels · balance sheet €1.85m
- Nutrifarma Wholesale of other food Heist-op-den-Berg · balance sheet €1.80m
- Azingro Wholesale of other food Heist-op-den-Berg · balance sheet €1.27m
- Dermax Wholesale of pharmaceutical and medical goods Liège · balance sheet €5.73m
- Nutrimed Manufacture of homogenised food preparations and dietetic food Dendermonde · balance sheet €3.89m
Frequently asked questions about Deba Pharma
What is the revenue of Deba Pharma?
Deba Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Deba Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0434737865 for Deba Pharma, if the company is VAT-registered. Its company number (CBE) is 0434.737.865.
Where is the registered office of Deba Pharma?
According to the CBE register, the registered office of Deba Pharma is in 8510 Kortrijk.
What is the equity of Deba Pharma?
At the close of the 2025 financial year, the equity of Deba Pharma amounts to 6,199,999 €, a solvency of 94.4% of total assets.
How many people work at Deba Pharma?
1.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Deba Pharma?
The register lists 7 active mandates at Deba Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Deba Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →